Acurx Pharmaceuticals, Inc. Common Stock
Symbol: ACXP (NASDAQ)
4.09
▼ (-0.24%) -0.010
Company Description:
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
Key Stats
- Today's Open: $4.08
- Today's High: $4.38
- Today's Low: $3.932
- Today's Volume: 66.47K
- Yesterday Close: $4.1
- Yesterday High: $4.81
- Yesterday Low: $4.1
- Yesterday Volume: 651.85K
- Last Min Volume: 0
- Last Min High: $4.093
- Last Min Low: $4.09
- Last Min VWAP: $0
Company Profile
- Name: Acurx Pharmaceuticals, Inc. Common Stock
- Website: https://www.acurxpharma.com
- Listed Date: 2021-06-25
- Location: STATEN ISLAND, NY
- Market Status: Active
- CIK Number: 0001736243
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.50M
- Round Lot: 100
- Outstanding Shares: 1.58M
- Asset Type: CS
RECENT FILINGS FOR ACXP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-05 | DEFA14A | View |
| 2025-08-04 | DEF 14A | View |
| 2025-07-31 | 8-K | View |
| 2025-07-24 | PRE 14A | View |
| 2025-07-23 | EFFECT | View |
| 2025-07-21 | CORRESP | View |
| 2025-07-21 | UPLOAD | View |
| 2025-07-17 | 8-K | View |
| 2025-07-15 | S-1 | View |
| 2025-07-09 | S-3 | View |
| 2025-06-27 | D | View |
| 2025-06-20 | 8-K | View |
| 2025-05-29 | EFFECT | View |
| 2025-05-29 | 424B3 | View |
| 2025-05-29 | ARS | View |
| 2025-05-29 | DEFA14A | View |
| 2025-05-29 | DEF 14A | View |
Latest News on ACXP